Isolation, characterization, and biological evaluation of bioactive alkaloids from traditional medicinal herbs: Therapeutic potential and mechanism of action

Introduction

Over 50% of currently approved pharmaceutical agents derive directly or indirectly from natural product sources, with alkaloids representing the most clinically significant chemical class [1] . These nitrogen-containing secondary metabolites exhibit remarkable structural diversity and biological activity, having provided humanity with analgesics (morphine), antimalarials (quinine), anticancer agents (vincristine, vinblastine), and cardiovascular drugs (reserpine). Traditional medicinal systems worldwide have empirically identified alkaloidrich plants for treating diverse ailments over millennia. Berberine, an isoquinoline alkaloid found predominantly in Berberis species, has attracted renewed research interest for its diverse pharmacological properties including antimicrobial, antidiabetic, and anticancer activities [2] . Clinical trials have demonstrated efficacy comparable to metformin for type 2 diabetes management, suggesting potential as an alternative therapeutic agent. The mechanism underlying berberine anticancer effects involves multiple pathways including AMPK activation, cell cycle arrest, and apoptosis induction. Vinca alkaloids from Catharanthus roseus remain essential chemotherapeutic agents decades after their initial discovery [3] . Vincristine and vinblastine exert cytotoxicity through microtubule destabilization, prev enting mitotic spindle formation and inducing cell death. Despite their therapeutic importance, vinca alkaloids occur at extremely low concentrations in plant tissues, driving efforts toward semi-synthetic modification and biotechnological production. The opioid alkaloids of Papaver somniferum represent both invaluable analgesics and substances of significant abuse potential [4] . Morphine remains the gold standard for severe pain management despite well-characterized tolerance and dependence liability. Research continues to seek opioid derivatives with improved therapeutic indices separating analgesia from adverse effects. This research aimed to systematically characterize alkaloid content and biological activities across five traditional medicinal plants, comparing extraction efficiencies, cytotoxic potencies, and antimicrobial spectra to inform standardization approaches for botanical medicine development [5] .

Material and Methods

Plant material

Authenticated plant materials were obtained from the Royal Botanic Garden Edinburgh and commercial suppliers with verified botanical identity. Voucher specimens were deposited at the University of Edinburgh Herbarium. Materials were dried at 40 °C to constant weight and ground to pass 40-mesh sieves prior to extraction.

Reagents and extraction protocol

All solvents were HPLC grade (Fisher Scientific, Loughborough, UK). Reference standards including berberine hydrochloride, vincristine sulfate, morphine hydrochloride, reserpine, and ephedrine hydrochloride were obtained from Sigma-Aldrich (purity ≥98%). Total alkaloids were extracted using acidified methanol (0.1% HCl) with ultrasonic assistance (3 × 30 min, 50 °C). Combined extracts were basified to pH 9.5 and partitioned into chloroform. Crude alkaloid fractions were purified by silica gel column chromatography eluting with chloroform-methanol gradients (95:5 to 70:30).

Analytical Methods

Total alkaloid content was determined gravimetrically after precipitation with Mayer reagent. Individual alkaloids were quantified by HPLC-UV (Agilent 1260 Infinity) using C18 column (250 × 4.6 mm, 5 μm) with gradient elution of acetonitrile-ammonium formate buffer. Structural confirmation employed ¹H and ¹³C NMR spectroscopy (Bruker Avance 600 MHz) and high-resolution mass spectrometry (Thermo Q Exactive).

Quality control

Method validation followed ICH guidelines for specificity, linearity, accuracy, precision, and robustness. Calibration curves demonstrated linearity (r² >0.999) over concentration ranges spanning two orders of magnitude. Recovery experiments yielded 94.6-102.3% with relative standard deviations below 5%. Quality control samples at three concentration levels were analyzed with each batch to monitor assay performance.

Results

Alkaloid content

Total alkaloid content varied substantially across the five species examined (Figure 1). Papaver somniferum demonstrated highest alkaloid accumulation (median 5.2% dry weight), consistent with its historical cultivation for opioid production. Berberis vulgaris root bark contained 3.8% alkaloids with berberine constituting approximately 65% of total alkaloid fraction. Catharanthus roseus leaves yielded 2.4% total alkaloids though vinca alkaloids represented less than 0.01% of dry weight, reflecting their trace occurrence.

Cytotoxicity screening

Cytotoxicity evaluation revealed vincristine demonstrating greatest potency against all three cancer cell lines with IC50 values of 0.4-1.2 μM (Figure 2). Berberine exhibited moderate cytotoxicity (IC50 8.6-15.2 μM) with greatest activity against HeLa cervical carcinoma cells. Morphine showed minimal cytotoxicity at concentrations up to 100 μM, consistent with its primary activity at opioid receptors rather than direct antiproliferative mechanisms.

Antimicrobial Activity

Antimicrobial screening demonstrated berberine possessed broadest activity spectrum with minimum inhibitory concentrations of 32 μg/mL against Staphylococcus aureus, 64 μg/mL against Candida albicans, and 128 μg/mL against Escherichia coli. Other alkaloids showed limited antimicrobial activity at tested concentrations, supporting the historical use of Berberis preparations specifically for infectious conditions.

Discussion

This comprehensive evaluation confirms substantial variation in alkaloid content and biological activities across traditional medicinal plants, emphasizing the importance of species-specific standardization for quality herbal products. The high total alkaloid content in Papaver species reflects selective breeding for opioid production over centuries [6] . Conversely, the trace concentrations of vinca alkaloids in Catharanthus necessitate processing enormous plant quantities for pharmaceutical production, driving research into alternative biosynthetic approaches. The superior cytotoxic potency of vincristine compared to other alkaloids reflects its specific mechanism targeting microtubule dynamics essential for cell division [7] . This mechanism selectivity enables therapeutic application despite minimal selectivity between normal and malignant cells, as rapidly dividing tumor cells demonstrate greatest sensitivity. Berberine cytotoxicity operates through distinct mechanisms involving mitochondrial dysfunction and AMPK activation, potentially enabling combination approaches.

Berberine antimicrobial activity validates traditional use of Berberis preparations for infectious diarrhea and wound infections [8] .

Acknowledgement

Acknowledgements Funding sourcesThis research was supported by the Biotechnology and Biological Sciences

References

1. Newman DJ, Cragg GM. Natural products as sources of new drugs over the nearly four decades from 1981 to 2019. Journal of Natural Products. 2020;83(3):770-803.
2. Imenshahidi M, Hosseinzadeh H. Berberine and barberry: a clinical review. Phytotherapy Research. 2019;33(3):504-523.
3. Moudi M, Go R, Yien CY, Nazre M. Vinca alkaloids. International Journal of Preventive Medicine. 2013;4(11):1231-1235.
4. Oniszczuk A, Olech M. Chemistry, biosynthesis and pharmacology of opioid alkaloids. Planta Medica. 2016;82(9):781-789.
5. Heinrich M, Appendino G, Efferth T, et al. Best practice in research -overcoming common challenges in phytopharmacological research. Journal of Ethnopharmacology. 2020;246:112230.
6. Beaudoin GA, Facchini PJ. Benzylisoquinoline alkaloid biosynthesis in opium poppy. Planta. 2014;240(1):1932.
7. Jordan MA, Wilson L. Microtubules as a target for anticancer drugs. Nature Reviews Cancer. 2004;4(4):253-265.
8. Habtemariam S. Berberine pharmacology and the gut microbiota: a hidden therapeutic link. Pharmacological Research. 2020;155:104722.
9. Tillhon M, Guamán Ortiz LM, Lombardi P, Scovassi AI. Berberine: new perspectives for old remedies. Biochemical Pharmacology. 2012;84(10):1260-1267.
10. Kumar A, Ekavali, Chopra K, et al. Current knowledge and pharmacological profile of berberine. European Journal of Pharmacology. 2015;761:288-297.
11. Zhu L, Shen H, Gu PQ, et al. Baicalin and berberine in the prevention and treatment of obesity. Phytomedicine. 2020;79:153324.
12. Kutchan TM. Alkaloid biosynthesis -the basis for metabolic engineering of medicinal plants. Plant Cell. 1995;7(7):1059-1070.
13. Facchini PJ. Alkaloid biosynthesis in plants: biochemistry, cell biology, molecular regulation. Annual Review of Plant Physiology. 2001;52:29-66.
14. Ziegler J, Facchini PJ. Alkaloid biosynthesis: metabolism and trafficking. Annual Review of Plant Biology. 2008;59:735-769.
15. Hagel JM, Facchini PJ. Benzylisoquinoline alkaloid metabolism: a century of discovery. Phytochemistry. 2013;91:52-65.
16. Matsuura HN, Fett-Neto AG. Plant alkaloids: main features, toxicity, and mechanisms of action. Plant Toxins. 2017;2:1-15.